| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/06/2005 | CN1209369C Cell death inducing protein and its coding sequence and use |
| 07/06/2005 | CN1209359C Novel dihydric indole compound, their preparation process and medicinal compositions containing them |
| 07/06/2005 | CN1209358C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/06/2005 | CN1209354C Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine |
| 07/06/2005 | CN1209353C Estrogen agonist/antagonist metabolites |
| 07/06/2005 | CN1209351C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR3 receptor antagonists |
| 07/06/2005 | CN1209160C Skin-infiltrating film of Chinese traditional medicine for treating paralysis resulting from central nerve trauma and its preparation method |
| 07/06/2005 | CN1209156C Medicinal wine for treating old injury recurrent pain |
| 07/06/2005 | CN1209154C Novel preparation process of Qingkailing injection |
| 07/06/2005 | CN1209146C Fumigant for treating prosopalgia and its preparing process |
| 07/06/2005 | CN1209139C Traditional Chinese medicine for treating vascular dementia and its preparing method |
| 07/06/2005 | CN1209112C Smilagenin and anzurogenin-D for treating Alzheimer's disease |
| 07/06/2005 | CN1209098C Methods and devices for providing prolonged drug therapy |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6914070 Ophthalmic compositions for treating ocular hypertension |
| 07/05/2005 | US6914065 Imidazo[1,2-C]pyrimidine derivatives as ligands for gaba receptors |
| 07/05/2005 | US6914063 Imidazo-pyrazine derivatives as ligands for GABA receptors |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6914056 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 07/05/2005 | US6914053 5-(hydroxymethyl)- or aminocarbonyl-2-(6-(alkoxyamino)-2-(optionally substituted ethynyl)purin-9-yl)tetrahydrofuran-3,4-diol derivatives; treatment of ischemia, asthma, leukopenia and neutropenia, cancer and inflammation. |
| 07/05/2005 | US6914044 Compounds and methods for modulating cell adhesion |
| 07/05/2005 | US6913925 Producing conditionally-immortalized brain tissues for treatment of parkinson's and nervous system disorders |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913770 Process for the extraction of valerian root |
| 07/05/2005 | CA2360677C Anticonvulsant derivatives useful in treating bulimia nervosa |
| 07/05/2005 | CA2309485C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 07/05/2005 | CA2274910C Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same |
| 07/05/2005 | CA2253545C Phosphatidic acid-comprising compositions |
| 07/05/2005 | CA2215793C Use of neuronal apoptosis inhibitor protein (naip) |
| 07/05/2005 | CA2199679C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
| 07/05/2005 | CA2165446C Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 07/05/2005 | CA2160128C Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 07/05/2005 | CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes |
| 07/05/2005 | CA2072541C Heterocyclic compounds, their production and use |
| 07/05/2005 | CA2064382C Pharmaceutical compounds |
| 06/30/2005 | WO2005058951A1 Sugar chain-lacking hepatocyte growth factor |
| 06/30/2005 | WO2005058858A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 06/30/2005 | WO2005058338A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | WO2005058336A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/30/2005 | WO2005058319A1 Methods and compositions |
| 06/30/2005 | WO2005035533A8 Modulators of serotonin receptors |
| 06/30/2005 | WO2005034932A3 Amino acid based compositions for the treatment of pathological conditions distinguished by insufficient mitochondrial function |
| 06/30/2005 | WO2005030148A3 Tetrahydroindolone derivatives for treatment of neurological conditions |
| 06/30/2005 | WO2005025574A3 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 06/30/2005 | WO2005023285A3 Agent and method for the treatment and prevention of tse and method for the production of said agent |
| 06/30/2005 | WO2004084809A3 Neuroprotective macrocylic compounds and methods for their use |
| 06/30/2005 | WO2004065614A3 Suppression of cytotoxic protein conformers |
| 06/30/2005 | WO2004055009A8 Novel compounds having selective inhibiting efect at gsk3 |
| 06/30/2005 | WO2004055006A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | WO2004055005A8 Novel compounds having selective inhibiting effect at gsk3 |
| 06/30/2005 | WO2004041826A8 Imidazopyrazinones and imidazotriazinones derivates as gaba-a receptor anxiolytic |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | US20050143470 therapeutic treatment of Porcine Respiratory Disease Complex (PRDC) in pigs and Bovine Respiratory Syndrome (BRS) in calves; oral treatment; veterinary medicine |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143408 Aporphine esters and their use in therapy |
| 06/30/2005 | US20050143403 Substituted pyrimidinones and pyrimidinthiones |
| 06/30/2005 | US20050143395 (2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-3-yl)-acetaldehyde, and, 3-{2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-piperidin-1-yl]-vinyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one; intermediates to risperidone |
| 06/30/2005 | US20050143391 Heterocyclic amides with alpha-4 integrin antagonist activity |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143388 Nitric oxide donors for treatment of disease and injury |
| 06/30/2005 | US20050143379 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 06/30/2005 | US20050143342 Administering sulfated polysaccharide such as cellulose sulfate, dextran sulfate, dermatan sulfate, chondroitin sulfate, pentosan sulfate, fucoidin, mannan sulfate, dextrin sulfate, curdlan sulfate, chitin sulfate, heparin or heparin sulfate for therapy and prophylaxis of fungal infection |
| 06/30/2005 | US20050143310 Novel remedies for neurodegenerative disease |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050142659 Purified populations of stem cells |
| 06/30/2005 | US20050142625 monoclonal antibodies or antigen-binding fragments having specific binding affinity to an epitope of protein kinases polypeptides, used for the diagnosis and treatment of various kinase-related diseases in humans |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142552 Susceptibility locus for schizophrenia |
| 06/30/2005 | US20050142546 Assays for identifying modulators of rhomboid polypeptides |
| 06/30/2005 | US20050142191 Pharmaceutical formulations of amyloid inhibiting compounds |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050142150 Botulinum toxin formulations |
| 06/30/2005 | US20050142132 Prevention and treatment of amyloidogenic disease |
| 06/30/2005 | US20050142128 Treatment for diseases of the eye inner ear and central nervous system |
| 06/30/2005 | US20050142110 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 06/30/2005 | US20050142102 Administering a hematopoietic growth factor such as granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor to a mammal; providing neuroprotection to the neural cells involved or to induce neurogenesis to recover from neuronal loss |
| 06/30/2005 | US20050142100 Tumor Necrosis Factor Binding Protein (TBP) or an isoform, mutein, fused protein, function derivative, active fraction, or salt; multiple sclerosis; corticosteroid; glatiramer |
| 06/30/2005 | US20050142098 Polyoxyethylene glycol conjugated neublastin polypeptide dimers; exhibit prolonged bioavailability |
| 06/30/2005 | US20050142072 Drug delivery into nose; controlling concentration into blood; using opioid or non-steroil antiinflammatory dryg |
| 06/30/2005 | US20050139485 applying a resonance conditioning frequencies, spectral energy pattern to a battery cell reaction system, act to accelerate and catalysis the reaction |
| 06/30/2005 | CA2792467A1 Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases |
| 06/30/2005 | CA2580663A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | CA2556342A1 Pharmaceutical composition of a sodium channel blocker and a selective serotonin uptake inhibitor |
| 06/30/2005 | CA2550610A1 Use of gaboxadol for treating insomnia |
| 06/30/2005 | CA2550505A1 Copper antagonist compounds |
| 06/30/2005 | CA2550168A1 Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-.alpha.]pyrimidin-6-one derivatives |
| 06/30/2005 | CA2550053A1 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 06/30/2005 | CA2549878A1 Glycosylation-deficient hepatocyte growth factor |
| 06/30/2005 | CA2549662A1 A method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity |
| 06/30/2005 | CA2549589A1 Prolinylarylacetamides |
| 06/30/2005 | CA2549303A1 Novel sodium channel |
| 06/30/2005 | CA2549072A1 Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease |
| 06/30/2005 | CA2549000A1 Method for treating neurological disorders |
| 06/30/2005 | CA2548781A1 Synthesis of a polymorph of 4-amino-5-chloro-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate |